CD4 and lupus nephritis: Long-term IL-2 treatment decreased the activity and proliferation of intrarenal conventional CD4+ T cells, which was accompanied by a clinical and histological improvement of lupus nephritis, according to research, while short-term IL-2 treatment increased the intrarenal Treg population in mice with active lupus nephritis [77].